IL-6 deficient mice show an impaired neutrophil response after C. albicans infection (402) and patients treated with the humanised monoclonal anti-IL-6R antibody tocilizumab, show transient neutropenia, all demonstrating the neutrophil mobilising properties of IL-6 (403–408). The gene discussed is IL6; the disease is neutropenia.